Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia

Leuk Lymphoma. 2021 Nov;62(11):2800-2803. doi: 10.1080/10428194.2021.1933476. Epub 2021 Jun 1.

Authors

Marie-Laure Boulland^{1

2}, Samuel Vic³, Florian Thonier⁴, Michel Ganard³, Thierry Lamy^{2

3}, Thierry Fest^{1

2}, Sophie de Guibert³, Cédric Pastoret^{1

2}

Affiliations

¹ Laboratoire d'Hématologie, Pôle de Biologie, CHU de Rennes, Rennes, France.
² INSERM, UMR1236, Equipe labellisée Ligue contre le Cancer, Rennes, France.
³ Service d'Hématologie Clinique, CHU de Rennes, Rennes, France.
⁴ INRIA, Rennes, France.

PMID: 34060965
DOI: 10.1080/10428194.2021.1933476

No abstract available

Publication types

Letter

MeSH terms

High-Throughput Nucleotide Sequencing
Humans
Immunoglobulin Heavy Chains / genetics
Immunoglobulin Variable Region / genetics
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Mutation
Prognosis

Substances

Immunoglobulin Heavy Chains
Immunoglobulin Variable Region